Vaginal, sexual and urinary symptoms following hysterectomy: a multi-centre randomized controlled trial

Women's Midlife Health

Table 2 Vaginal and sexual symptoms pre-operatively, 6-months and 1-year following TAH, NDVH and TLH

Pelvic organ function	TAH	NDVH	TLH	Significance
VSS pre-op [median, (IQ1-IQ3))]	6 (2–8)	6 (4–8.5)	4 (2–10.5)	p = 0.63
VSS 6-months [median (IQ1-IQ3)]	4 (0–8), p < 0.001^#	4 (0–8), p < 0.001^#	3 (0–6), p < 0.001^#
VSS 1-year [median (IQ1-IQ3)]	4 (0–8), p < 0.001^#	5 (0–8), p < 0.001^#	4 (0–10), p < 0.001^#
SSS pre-op [median, (IQ1-IQ3))]	0 (0–11.5)	0 (0–0)	0 (0–0)	p = 0.07
SSS 6-months [median (IQ1-IQ3)]	0 (0–10), p < 0.05^#	0 (0–0), p = 0.69^#	0 (0–0), p = 0.06^#
SSS 1-year [median (IQ1-IQ3)]	0 (0–14), p = 0.08^#	0 (0–0), p = 0.46^#	0 (0–4.2), p < 0.05^#

^#p values indicate the significance of the pelvic organ function domain score for the respective route at 6-months and 1-year compared to the pre-operative score
TAH – n = 49 for all at 6-months except SSS (n = 23), n = 47 for all at 1-year except SSS (n = 22)
NDVH– n = 48 for all at 6-months except SSS (n = 29), n = 45 for all at 1-year except SSS (n = 28)
TLH– n = 48 for all at 6-months except SSS (n = 23), n = 47 for all at 1-year except SSS (n = 22)

ISSN: 2054-2690